News

VA and DoD medical centers serve a patient population that frequently presents with complex orthopedic needs: combat injuries, repetitive stress, and compromised bone quality. These are demanding clinical environments with rigorous product evaluation standards and structured formulary processes. When a healthcare system of this nature moves to incorporate a new implant technology, it reflects a considered clinical decision, not simply a commercial one.

Diamond Orthopedic's faceted screw design was developed to address real biomechanical limitations of traditional helical threadforms. The patented geometry reduces insertion torque by approximately 50% compared to conventional screws, based on studies conducted at Orthokinetic Testing Technologies (data on file). In an in vivo ovine study, the faceted design demonstrated 61% greater pullout strength compared to the leading helical screw at two weeks post-surgery. In cases involving compromised or osteopenic bone, those differences are clinically meaningful.

As Vince Proffitt, President of Spartan Medical, noted in the announcement, the technology offers "a 50% reduction in insertion torque with a higher pullout strength," describing it as "the best of both worlds" for a variety of extremity procedures.

When a surgeon uses a product that simplifies a case, they finish faster, turn the room over sooner, and fit more procedures into a day, and that efficiency is something every surgical team feels. Diamond's faceted design reduces insertion torque by approximately 50% compared to traditional helical screws, meaning less manual effort, less risk of stripping or microfracturing bone mid-case, and a cleaner insertion experience. The 61% greater pullout strength at two weeks post-surgery means surgeons move forward with confidence in the fixation, fewer intraoperative adjustments, less second-guessing, and less time managing complications that trace back to screw purchase. Efficiency in the OR is not a soft benefit. It is the foundation of lasting surgeon relationships and the partnerships that grow from them.

The partnership also reflects Diamond's stated product strategy. CEO Roy Bivens noted that the company's goal is to "selectively expand our product offering in applications where the biomechanical advantages of the faceted screw are most evident," including recent releases for metacarpal and proximal phalanx procedures in the hand, as well as several forefoot applications. VA and DoD facilities serve as an important extension of that strategy, reaching patient populations where strong fixation in complex anatomy is particularly relevant.